// App-Quantinova.ai

1069 : A measure of intratumor heterogeneity to predict metastasis and metastasis-free survival in patients with triple-negative breast cancer.

Researchers

Presenter

  • Yucai Wang

Principal Investigators

  • Fang Yang

  • Yanru Wang

  • Victor Tsu-Shih Chang

  • Xiaoxiang Guan

Medical Centers

  • Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ

  • Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China

  • Duke Cancer Institute, Duke University Medical Center, Durham, NC

  • Section of Hematology/Oncology, VA New Jersey Health Care System, East Orange, NJ

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • Chromosome 7

  • Cyclin D1

  • Epidermal growth factor receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved